Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran

被引:6
|
作者
Diogo, Catia [1 ]
Duarte, Josiana [1 ]
Nzwalo, Hipolito [2 ]
Sobral, Sofia [1 ]
Pestana, Paula [3 ]
Rita, Henrique [3 ]
Costa, Jose Sousa e [1 ]
机构
[1] Unidade Local Saude Litoral Alentejano ULSLA, Dept Internal Med, Santiago, Chile
[2] Ctr Hosp Algarve CHA, Dept Neurol, Natl Inst Med Emergency INEM, Nottingham, England
[3] Natl Inst Med Emergency INEM, Unidade Local Saude Litoral Alentejano, Dept Internal Med, Oporto, Portugal
来源
关键词
D O I
10.1016/j.ajem.2014.04.021
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The novel oral anticoagulants (NOACs) are indicated for stroke and systemic embolism prophylaxis in patients with nonvalvular atrial fibrillation (AF). Very few cases of intravenous recombinant tissue plasminogen activator (IV rt-PA) in patients under treatment with NOACs have been described. The decision to thrombolyze patients under NOACs is complex and requires a balance between the benefits of treatment and the risk of symptomatic hemorrhagic complications. We describe an unusual case of treatment IV rt-PA for acute ischemic stroke in a patient receiving dabigatran for AF. The decision to treat the patient with IV rt-PA was based on the combination of normal coagulation times with the long time elapsed after the last dose of dabigatran, when the drug effect was predictably residual.
引用
收藏
页码:1435 / +
页数:2
相关论文
共 50 条
  • [1] Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment
    Meyer, Dawn
    Chu, Frank
    Derry, Katrina
    Hailey, Lovella
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2019, 59 : 355 - 357
  • [2] Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran
    Consuelo Matute, Maria
    Guillan, Marta
    Garcia-Caldentey, Juan
    Buisan, Javier
    Aparicio, Maria
    Masjuan, Jaime
    Alonso de Lecinana, Maria
    [J]. THROMBOSIS AND HAEMOSTASIS, 2011, 106 (01) : 178 - 179
  • [3] Intravenous Thrombolysis in a Stroke Patient Taking Dabigatran
    Lee, Vivien H.
    Conners, James J.
    Prabhakaran, Shyam
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (08): : 916.e11 - 916.e12
  • [4] Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab
    Krzesinski, F.
    [J]. ACTA CARDIOLOGICA, 2019, 74 (05) : 456 - 456
  • [5] Intravenous Thrombolysis in a Stroke Patient Taking Dabigatran Response
    Lee, Vivien
    Conners, James J.
    Prabhakaran, Shyam
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (06): : 894 - 894
  • [6] Intravenous thrombolysis following dabigatran reversal in a patient with acute embolic stroke after atrial fibrillation ablation
    Chen, Yi-Sheng
    Lin, Chin-Yu
    [J]. JOURNAL OF ARRHYTHMIA, 2024,
  • [7] Intravenous thrombolysis for acute stroke in a patient on treatment with rivaroxaban
    Lucia Nardetto
    Simone Tonello
    Luigi Zuliani
    Bruno Giometto
    [J]. Neurological Sciences, 2015, 36 : 2291 - 2292
  • [8] Intravenous thrombolysis for acute stroke in a patient on treatment with rivaroxaban
    Nardetto, Lucia
    Tonello, Simone
    Zuliani, Luigi
    Giometto, Bruno
    [J]. NEUROLOGICAL SCIENCES, 2015, 36 (12) : 2291 - 2292
  • [9] Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab - a case report
    Mutzenbach, Johannes Sebastian
    Pikija, Slaven
    Otto, Ferdinand
    Halwachs, Ursula
    Weymayr, Friedrich
    Sellner, Johann
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (11): : 889 - 892
  • [10] Intravenous Thrombolysis After Reversal of Dabigatran With Idarucizumab in Acute Ischemic Stroke: A Case Report
    Xie, Dan
    Wang, Xuefan
    Li, Yao
    Chen, Ruiling
    Zhao, Yingying
    Xu, Chunling
    Zhang, Qian
    Zhang, Yongbo
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2021, 13